Tolinapant clinical trials

A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)

This study looked at a new drug, tolinapant, combined with Decitabine and Cedazuridine, for people with a difficult-to-treat type of blood cancer called peripheral T-cell lymphoma. Researchers wanted to understand if the drug combination was safe and how well it worked. The study was stopped early because a safe dose couldn't be found.